Renflexis and Back pain - a phase IV clinical study of FDA data

Summary:

Back pain is reported as a side effect among people who take Renflexis (infliximab-abda), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Benadryl, and have Crohn's disease.

The phase IV clinical study analyzes which people have Back pain when taking Renflexis. It is created by eHealthMe based on reports of 1,311 people who have side effects when taking Renflexis from the FDA, and is updated regularly.

What is Renflexis?

Renflexis has active ingredients of infliximab-abda. eHealthMe is studying from 1,316 Renflexis users. Check the latest studies of Renflexis.

What is Back pain?

Back pain is found to be associated with 3,222 drugs and 4,710 conditions by eHealthMe. Check the latest studies of Back pain.

On Jul, 09, 2026

1,311 people reported to have side effects when taking Renflexis.
Among them, 42 people (3.2%) have Back pain.

Among these 42 people:

How long have people been on Renflexis when they have Back pain? *

What is the gender of people who have Back pain when taking Renflexis? *

female: 51.22 %
male: 48.78 %

What is the age of people who have Back pain when taking Renflexis? *

What are other drugs people take besides Renflexis? *

What are other side effects people have besides Back pain? *

Chest Pain: 13 people, 30.95%
Headache (pain in head): 10 people, 23.81%
Dyspnea (difficult or laboured breathing): 10 people, 23.81%
Infusion Related Reaction: 10 people, 23.81%
Joint Pain: 8 people, 19.05%
Malaise (a feeling of general discomfort or uneasiness): 8 people, 19.05%
Pain: 7 people, 16.67%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 7 people, 16.67%
Chills (felling of cold): 7 people, 16.67%
Hypotension (abnormally low blood pressure): 6 people, 14.29%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 14 people, 33.33%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 9 people, 21.43%
Ankylosing Spondylitis (type of arthritis affecting the spine): 6 people, 14.29%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 11.90%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 7.14%
Pain: 3 people, 7.14%
Pyoderma Gangrenosum (ulcerating condition of skin that results in heaped borders with a typical appearance): 2 people, 4.76%
Behcet's Syndrome (involves inflammation of the blood vessels): 2 people, 4.76%
Neoplasm Malignant (cancer tumour): 1 person, 2.38%
Inflammatory Bowel Disease: 1 person, 2.38%

* Approximation only. Some reports may have incomplete information.

Do you take Renflexis and have Back pain?

- Check whether Back pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Renflexis:

Renflexis (1,316 reports)

Back pain treatments and more:

Back pain (379,875 reports)

Browse all side effects of Renflexis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Back pain:

Back pain (3,222 drugs)

Browse all the conditions that are associated with Back pain:

Back pain (4,710 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on infliximab-abda (the active ingredients of Renflexis) and Renflexis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.